Sharp Biomedical
Minimally invasive spinal toolsets and implants for outpatient clinics
Community-submitted · content unverified. This organization has not verified ownership or the information in this profile.
About
Sharp Biomedical is an early-stage medical device company developing toolsets and implants that move spinal procedures out of the hospital and into outpatient surgery centres and pain clinics. Its first product in development, Altitude by Sharp, is an expandable interspinous spinal fixation implant inserted through a roughly 1-inch incision, designed to limit bone dissection, use less metal and be placed under moderate anaesthesia; the company lists a planned Q4 2027 launch. Led by CEO Dan Newman, it closed a pre-seed round led by gener8tor 1889 with angel investors in October 2026 to fund development and testing of its first system, according to FinSMEs.
- Website
- sharpbiomedical.com
- Stage
- pre-seed
- Added via
- web
- Ownership
- unclaimed